Sounds promising but...

Discussion in 'Exact Sciences' started by Anonymous, Dec 28, 2014 at 12:35 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    For reps who are on this contract, I would keep interviewing. Until they commit, i.e., rollover as Exact employees with stake in overall success like stock options, there is no trust/loyalty on both sides.
     

  2. Anonymous

    Anonymous Guest

    Does their go to market strategy include hiring 100's of reps to sell to private practice physicians???
     
  3. Anonymous

    Anonymous Guest

    Exact Sciences management and employees are making major money with stock. Until they commit to those contract reps, this is all a "get stock up" and sell company.

    In transactions from Oct. 16 to Oct. 20, the four officials exercised their rights to buy shares of Exact stock at prices ranging from 83 cents per share to $10.18 per share, then subsequently sold those shares at prices ranging from $22.84 to $23.93. CEO Kevin Conroy netted nearly $9.1 million, COO Maneesh Arora pocketed $5.6 million, chief science officer Graham Lidgard made about $3.1 million, and board member Sally Crawford pulled in about $1.6 million. Those ranked among the biggest recent payouts for public company executives and board members selling stock, according to Thomson Reuters data published by Barron’s.
     
  4. Anonymous

    Anonymous Guest

    You can't exercise stock options for multiple yrs at the least. The people who are making $ from stock were with Exact from day 1. The rest will have to sit and wait awhile before doing anything.
     
  5. Anonymous

    Anonymous Guest


    These facts alone show they are out for themselves and screw the rest let's go cheap and hire CSO reps .
     
  6. Anonymous

    Anonymous Guest

    Is Doug director of sales here?
     
  7. Anonymous

    Anonymous Guest

    Why